BackTable Urology
Ep. 206 Biochemical Recurrence: Insights from AUA/ASTRO/SUO Guidelines with Dr. Todd Morgan
Dr. Todd Morgan
I think that's it. It's two things. It's one, sometimes there are some benign glands that we leave behind, right? You're right. If we have a patient who's got more favorable risk disease, especially they're young and we're doing everything possible to preserve potency, we are cutting it close. And so could we leave some glands, benign glands behind? Yeah.
0
💬
0
Comments
Log in to comment.
There are no comments yet.